Tieni traccia delle ultime attività di insider trading Fulcrum Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Fulcrum Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
May 09, 2025 | PRINCIPAL ACCOUNTING OFFICER | -498.00 | $5.06 | -$2.52K | SELL | -3.42% | 14.06K | May 08 | ||
May 09, 2024 | PRINCIPAL ACCOUNTING OFFICER | -236.00 | $7.76 | -$1.83K | SELL | -2.00% | 11.57K | May 07 | ||
Mar 08, 2024 | VICE PRESIDENT, FINANCE | -4.88K | $11.72 | -$57.22K | SELL | -29.26% | 11.81K | Mar 08 | ||
Mar 05, 2024 | SEE REMARKS | 43.36K | $11.35 | $492.03K | BUY | ∞ | 43.36K | Mar 04 | ||
May 11, 2023 | PRINCIPAL ACCOUNTING OFFICER | -210.00 | $3.31 | -$695.10 | SELL | -1.30% | 15.99K | May 10 | ||
Jan 24, 2023 | 10% OWNER | 1.92M | $13.00 | $25.00M | BUY | 19.85% | 11.61M | Jan 20 | ||
Jan 13, 2023 | INTERIM PRESIDENT & CEO | -6.77K | $15.00 | -$101.49K | SELL | -1.34% | 499.86K | Jan 13 | ||
Jan 06, 2023 | 10% OWNER | 180.70K | $7.28 | $1.31M | BUY | 1.90% | 9.69M | Jan 04 | ||
Dec 29, 2022 | 10% OWNER | 4.09K | $5.99 | $24.51K | BUY | 0.04% | 9.51M | Dec 27 | ||
Dec 21, 2022 | 10% OWNER | 98.79K | $5.90 | $582.81K | BUY | 1.05% | 9.50M | Dec 19 | ||
Dec 16, 2022 | 10% OWNER | 2.40M | $5.44 | $13.07M | BUY | 34.33% | 9.40M | Dec 14 - Dec 16 | ||
Jun 08, 2022 | DIRECTOR | 0.00 | $7.96 | -$17.84K | SELL-OPTIONS | 0.00% | 506.63K | Jun 07 | ||
Jun 06, 2022 | DIRECTOR | 0.00 | $7.92 | -$10.49K | SELL-OPTIONS | 0.00% | 506.63K | Jun 02 - Jun 06 | ||
Apr 11, 2022 | DIRECTOR | 0.00 | $15.93 | -$91.08K | SELL-OPTIONS | 0.00% | 506.63K | Apr 07 | ||
Apr 05, 2022 | DIRECTOR | 0.00 | $16.00 | -$1.54M | SELL-OPTIONS | 0.00% | 506.63K | Apr 01 - Apr 05 | ||
Aug 12, 2021 | CHIEF SCIENTIFIC OFFICER | 0.00 | $12.72 | -$505.42K | SELL-OPTIONS | 0.00% | 0.00 | Aug 10 | ||
Aug 12, 2021 | SEE REMARKS | 0.00 | $14.13 | -$754.60K | SELL-OPTIONS | 0.00% | 0.00 | Aug 10 - Aug 11 | ||
Jun 29, 2021 | CHIEF MEDICAL OFFICER | 1.10K | $9.16 | $10.08K | BUY | ∞ | 1.10K | Jun 28 | ||
Jun 29, 2021 | SVP, GENERAL COUNSEL | 1.09K | $9.01 | $9.80K | BUY | ∞ | 1.09K | Jun 28 | ||
Jun 29, 2021 | VP FINANCE & ACCOUNTING | 2.30K | $9.00 | $20.70K | BUY | ∞ | 2.30K | Jun 28 | ||
Jun 29, 2021 | DIRECTOR | 10.00K | $9.16 | $91.60K | BUY | 12.39% | 90.71K | Jun 28 | ||
Mar 17, 2021 | SEE REMARKS | -10.00K | $12.16 | -$121.58K | SELL | -1.94% | 506.63K | Mar 15 - Mar 16 | ||
Feb 24, 2021 | VP FINANCE & ACCOUNTING | 0.00 | $11.28 | -$34.38K | SELL-OPTIONS | 0.00% | 15.21K | Feb 22 | ||
Feb 18, 2021 | SEE REMARKS | -8.21K | $14.27 | -$117.20K | SELL | -1.57% | 516.63K | Feb 16 | ||
Jan 25, 2021 | VP FINANCE & ACCOUNTING | -6.61K | $14.00 | -$92.50K | SELL | -30.28% | 15.21K | Jan 21 | ||
Jan 22, 2021 | SEE REMARKS | -10.00K | $12.08 | -$120.83K | SELL | -1.87% | 524.85K | Jan 20 |
Sfoglia insider trading su tutte le azioni.